VISIOPHARM A/S: Financial statements 2024
CVR: 26186676
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
VISIOPHARM A/S (CVR 26186676) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 118,186,000 and a net result of DKK -17,363,000 compared with DKK -30,288,000 the year before. That is an increase of 5.4% compared with the year before. The profit margin was -14.7%. Equity in the 2024 report amounted to DKK 9,155,000. The solvency ratio was 7.7%. The company had 88 employees in the financial year.
- Revenue
- DKK 118,186,000
- Gross Profit
- DKK 90,153,000
- Profit/Loss
- DKK -17,363,000
- Equity
- DKK 9,155,000
- Total Assets
- DKK 118,419,000
- Employees
- 88
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 118.2M | 90.2M | -17.4M | 9.2M | 88 |
| 2023 | 112.1M | 86.8M | -30.3M | 25.5M | 96 |
| 2022 | 136M | 84.2M | -20.6M | 33.9M | 105 |
| 2021 | 108.5M | 45.3M | -41.3M | 59.4M | - |
| 2020 | 84.3M | 44.5M | -26.3M | 100.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout VISIOPHARM A/S
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.